• Article

Studying Cancer as an Adverse Outcome from Nononcological Therapies

Citation

Midkiff, K., Harris, D., Gilsenan, A., & Andrews, E. (2015). Studying Cancer as an Adverse Outcome from Nononcological Therapies: Review of the Food and Drug Administration's Postmarketing Commitment Database (Meeting Abstract. Pharmacoepidemiology and Drug Safety, 24(S1), 448-449. DOI: 10.1002/pds.3838